Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate and Ciprofloxacin (AC+C) in the Outpatient Care of Chemotherapy-induced Fever in Adult Haematology Patients. AC-CIF Protocol

NCT07483736 is registered in ClinicalTrials.gov with Versailles Hospital as lead sponsor.

NCT NCT07483736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07483736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate and Ciprofloxacin (AC+C) in the Outpatient Care of Chemotherapy-induced Fever in Adult Haematology Patients. AC-CIF Protocol
Lead sponsor
Versailles Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 31, 2026
Completion date
September 30, 2028
Enrollment
1,526 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

c15.378